Evaluation of the Veriton SPECT/CT System

Mayo Clinic

Status: Enrolling

Conditions: Focus of Study is Comparison of 2 Types of Gamma Cameras

Treatments: Diagnostic Test: Veriton SPECT/CT

Study type: Interventional

Funder types: Other

Identifiers

NCT04722185

20-001511

Details and patient eligibility

About

The main purpose of this study is to evaluate a new type of gamma camera (the Veriton system) that provides a significant gain in system sensitivity and improved image quality compared to a conventional gamma camera that can achieve equal or better image quality than a standard SPECT/CT system.

Enrollment: 300 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adults age 18 years or older.
• Currently scheduled to undergo a nuclear medicine exam.

Exclusion criteria

• Individuals under 18 years of age.
• Unwilling/unable to sign an informed consent form.
• Unable to lie on a Veriton imaging table for up to 40 minutes.

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

300 participants in 1 patient group

Evaluation of the Veriton SPECT/CT system

Experimental group

Description:

To determine if the Veriton system can achieve equal or better image quality than a standard SPECT/CT system.

Treatment:

Diagnostic Test: Veriton SPECT/CT